Clinical trial
Danish Osteoporosis Prevention Study
NCT00252408 · University of Aarhus, Other · Completed
Key facts
| NCT number | NCT00252408 |
|---|---|
| Title | Danish Osteoporosis Prevention Study |
| Official title | Danish Osteoporosis Prevention Study |
| Lead sponsor | University of Aarhus, Other |
| Collaborators | Karen Elise Jensen Foundation Novo Nordisk A/S Industry LEO Pharma Novartis |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Osteoporosis |
| Intervention type | Drug |
| Interventions | Hormone replacement therapy |
| Enrollment | 2,000 |
| Start date | Oct 1, 1990 |
| Completion | Dec 1, 2003 |
| First posted | Nov 11, 2005 |
| Last update posted | Sep 4, 2009 |
| Countries | Denmark |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: